Jill Cavanaugh

554 total citations · 1 hit paper
12 papers, 417 citations indexed

About

Jill Cavanaugh is a scholar working on Biological Psychiatry, Molecular Biology and Oncology. According to data from OpenAlex, Jill Cavanaugh has authored 12 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biological Psychiatry, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Jill Cavanaugh's work include Tryptophan and brain disorders (5 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jill Cavanaugh is often cited by papers focused on Tryptophan and brain disorders (5 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jill Cavanaugh collaborates with scholars based in United States, Canada and Germany. Jill Cavanaugh's co-authors include Alfredo Castro, Karen McGovern, Jeremy H. Tchaicha, Mark Manfredi, Roberta Zappasodi, Taha Merghoub, Dmitriy Zamarin, Stephane Pourpe, Ivan Cohen and Luís Felipe Campesato and has published in prestigious journals such as Nature Communications, Cancer Research and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Jill Cavanaugh

11 papers receiving 413 citations

Hit Papers

Blockade of the AHR restricts a Treg-macrophage suppressi... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
    2020 335 citations Luís Felipe Campesato, Sadna Budhu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Cavanaugh United States 5 183 145 108 102 55 12 417
Jessica Godin-Ethier Canada 8 208 1.1× 250 1.7× 186 1.7× 198 1.9× 73 1.3× 11 635
Paul Waeltz United States 7 105 0.6× 135 0.9× 149 1.4× 95 0.9× 12 0.2× 14 385
Helena Sterle Argentina 14 107 0.6× 169 1.2× 13 0.1× 96 0.9× 40 0.7× 23 413
Leonie Zeitler Germany 6 131 0.7× 223 1.5× 43 0.4× 53 0.5× 139 2.5× 6 393
M. Carmen Lafita‐Navarro United States 9 46 0.3× 322 2.2× 66 0.6× 69 0.7× 116 2.1× 15 440
Nofit Borenstein‐Auerbach United States 7 42 0.2× 218 1.5× 60 0.6× 59 0.6× 88 1.6× 9 330
Yuki Toda Japan 12 71 0.4× 246 1.7× 12 0.1× 69 0.7× 77 1.4× 36 423
Marina S. Konkova Russia 13 86 0.5× 283 2.0× 18 0.2× 43 0.4× 146 2.7× 27 523
Maxwell N. Skor United States 8 43 0.2× 237 1.6× 7 0.1× 159 1.6× 68 1.2× 14 488
Н. Н. Вейко Russia 16 115 0.6× 388 2.7× 17 0.2× 51 0.5× 239 4.3× 46 710

Countries citing papers authored by Jill Cavanaugh

Since Specialization
Citations

This map shows the geographic impact of Jill Cavanaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Cavanaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Cavanaugh more than expected).

Fields of papers citing papers by Jill Cavanaugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Cavanaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Cavanaugh. The network helps show where Jill Cavanaugh may publish in the future.

Co-authorship network of co-authors of Jill Cavanaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Cavanaugh. A scholar is included among the top collaborators of Jill Cavanaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Cavanaugh. Jill Cavanaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Haines, Eric, Víctor R. De Jesús, Daniel Hidalgo, et al.. (2026). The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers. Nature Cancer. 7(1). 116–130.
2.
Haines, Eric, Víctor R. De Jesús, Daniel Hidalgo, et al.. (2024). Abstract 3296: IK-595, a best-in-class MEK-RAF molecular glue, drives broad and potent anti-tumor activity across RAS-MAPK pathway-altered cancers as a monotherapy and in combination. Cancer Research. 84(6_Supplement). 3296–3296. 2 indexed citations
3.
Haines, Eric, Michael Burke, Víctor R. De Jesús, et al.. (2023). Abstract PR10: IK-595, a MEK-RAF complex inhibitor, obviates CRAF mediated resistance resulting in superior RAS/MAPK pathway inhibition and anti-tumor activity in RAS/RAF altered cancers. Molecular Cancer Research. 21(5_Supplement). PR10–PR10. 1 indexed citations
4.
Punkosdy, George A., Jill Cavanaugh, Collin M. Bantle, et al.. (2023). Abstract 1646: IK-930, a paralog-selective TEAD inhibitor for treating YAP/TAZ-TEAD dependent cancers. Cancer Research. 83(7_Supplement). 1646–1646. 8 indexed citations
5.
McGovern, Karen, Alfredo Castro, Jill Cavanaugh, et al.. (2022). Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression. Molecular Cancer Therapeutics. 21(8). 1261–1272. 27 indexed citations
6.
Amidon, Benjamin, Jill Cavanaugh, Katie O’Callaghan, et al.. (2021). Abstract P216: IK-930 mediated TEAD inhibition decreases and delays tumor growth and enhances targeted apoptosis in lung and colon cancer xenografts when combined with MEK or EGFR inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P216–P216. 7 indexed citations
7.
Campesato, Luís Felipe, Sadna Budhu, Jeremy H. Tchaicha, et al.. (2020). Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nature Communications. 11(1). 4011–4011. 335 indexed citations breakdown →
8.
McGovern, Karen, Alfredo Castro, Jill Cavanaugh, et al.. (2020). 448 Discovery of clinical candidate IK-175, a selective orally active AHR antagonist. Regular and Young Investigator Award Abstracts. A272.1–A272. 3 indexed citations
9.
Tchaicha, Jeremy H., Sílvia Coma, Jill Cavanaugh, et al.. (2019). Abstract 4131: Overcoming aryl hydrocarbon receptor mediated tumor immunosuppression. Cancer Research. 79(13_Supplement). 4131–4131. 1 indexed citations
10.
Coma, Sílvia, Jill Cavanaugh, James Nolan, et al.. (2018). Abstract 3757: Targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine. Cancer Research. 78(13_Supplement). 3757–3757. 1 indexed citations
11.
Tchaicha, Jeremy H., Karen McGovern, Luís Felipe Campesato, et al.. (2018). Abstract 4723: Targeting the IDO and TDO pathway through inhibition of the aryl hydrocarbon receptor. Cancer Research. 78(13_Supplement). 4723–4723. 2 indexed citations
12.
Nigim, Fares, Jill Cavanaugh, Anoop P. Patel, et al.. (2015). Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. Journal of Neuropathology & Experimental Neurology. 74(7). 710–722. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Godin-Ethier Breakdown of academic impact, for papers by Paul Waeltz Breakdown of academic impact, for papers by Helena Sterle Breakdown of academic impact, for papers by Leonie Zeitler Breakdown of academic impact, for papers by M. Carmen Lafita‐Navarro Breakdown of academic impact, for papers by Nofit Borenstein‐Auerbach Breakdown of academic impact, for papers by Yuki Toda Breakdown of academic impact, for papers by Marina S. Konkova Breakdown of academic impact, for papers by Maxwell N. Skor Breakdown of academic impact, for papers by Н. Н. Вейко
Rankless by CCL
2026